Dr. Martens plc
DOCMF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $2 | $3 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | -10.2% | -12.3% | 10.1% | – |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 65% | 57.3% | 56.4% | 59.7% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 14% | 22.4% | 20.4% | 29.3% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 0.6% | 7.9% | 12.9% | 19.9% |
| EPS Diluted | 0.005 | 0.07 | 0.13 | 0.18 |
| % Growth | -92.9% | -46% | -27.8% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |